Korro Bio, Inc.

General ticker "KRRO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $243.9M (TTM average)

Korro Bio, Inc. follows the US Stock Market performance with the rate: 17.4%.

Estimated limits based on current volatility of 3.6%: low 11.07$, high 11.90$

Factors to consider:

  • Total employees count: 104 as of 2024
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [14.23$, 44.22$]
  • 2025-12-31 to 2026-12-31 estimated range: [8.10$, 26.60$]

Financial Metrics affecting the KRRO estimates:

  • Negative: with PPE of -4.4 at the end of fiscal year the price was very high
  • Negative: Operating cash flow per share per price, % of -16.15 <= 0.06
  • Negative: negative Operating income
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 70.90 > 64.46

Similar symbols

Short-term KRRO quotes

Long-term KRRO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $2.27MM
Operating Expenses $59.00MM $84.53MM $94.18MM
Operating Income $-59.00MM $-84.53MM $-91.91MM
Non-Operating Income $0.98MM $3.39MM $8.47MM
Interest Expense $0.12MM $0.00MM $0.00MM
R&D Expense $42.20MM $57.25MM $63.64MM
Income(Loss) $-58.02MM $-81.14MM $-83.44MM
Taxes $0.01MM $0.03MM $0.14MM
Profit(Loss)* $-58.03MM $-81.17MM $-83.58MM
Stockholders Equity $-99.03MM $169.91MM $160.41MM
Assets $73.74MM $221.66MM $226.24MM
Operating Cash Flow $-53.65MM $-67.28MM $-60.07MM
Capital expenditure $5.21MM $7.84MM $17.90MM
Investing Cash Flow $11.06MM $11.16MM $-123.35MM
Financing Cash Flow $0.02MM $187.76MM $69.36MM
Earnings Per Share** $-227.58 $-53.09 $-9.37

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.